IBDEI0HJ ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8520,1,3,0)
 ;;=3^Visual Field Defect
 ;;^UTILITY(U,$J,358.3,8520,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,8520,2)
 ;;=Visual Field Defect^126859
 ;;^UTILITY(U,$J,358.3,8521,0)
 ;;=363.70^^58^610^4
 ;;^UTILITY(U,$J,358.3,8521,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8521,1,3,0)
 ;;=3^Choroidal Detachment NOS
 ;;^UTILITY(U,$J,358.3,8521,1,4,0)
 ;;=4^363.70
 ;;^UTILITY(U,$J,358.3,8521,2)
 ;;=^276841
 ;;^UTILITY(U,$J,358.3,8522,0)
 ;;=365.24^^58^610^28
 ;;^UTILITY(U,$J,358.3,8522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8522,1,3,0)
 ;;=3^Glaucoma,Residual Angle Closure
 ;;^UTILITY(U,$J,358.3,8522,1,4,0)
 ;;=4^365.24
 ;;^UTILITY(U,$J,358.3,8522,2)
 ;;=^268758
 ;;^UTILITY(U,$J,358.3,8523,0)
 ;;=365.65^^58^610^34
 ;;^UTILITY(U,$J,358.3,8523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8523,1,3,0)
 ;;=3^Glaucoma,Traumatic
 ;;^UTILITY(U,$J,358.3,8523,1,4,0)
 ;;=4^365.65
 ;;^UTILITY(U,$J,358.3,8523,2)
 ;;=^268780
 ;;^UTILITY(U,$J,358.3,8524,0)
 ;;=365.89^^58^610^23
 ;;^UTILITY(U,$J,358.3,8524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8524,1,3,0)
 ;;=3^Glaucoma,Oth Specified
 ;;^UTILITY(U,$J,358.3,8524,1,4,0)
 ;;=4^365.89
 ;;^UTILITY(U,$J,358.3,8524,2)
 ;;=^88069
 ;;^UTILITY(U,$J,358.3,8525,0)
 ;;=365.05^^58^610^38
 ;;^UTILITY(U,$J,358.3,8525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8525,1,3,0)
 ;;=3^Opn Ang w/ brdrlne fnd-Hi Risk
 ;;^UTILITY(U,$J,358.3,8525,1,4,0)
 ;;=4^365.05
 ;;^UTILITY(U,$J,358.3,8525,2)
 ;;=^340511
 ;;^UTILITY(U,$J,358.3,8526,0)
 ;;=365.06^^58^610^40
 ;;^UTILITY(U,$J,358.3,8526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8526,1,3,0)
 ;;=3^Prim Ang Clos w/o Glauc Dmg
 ;;^UTILITY(U,$J,358.3,8526,1,4,0)
 ;;=4^365.06
 ;;^UTILITY(U,$J,358.3,8526,2)
 ;;=^340512
 ;;^UTILITY(U,$J,358.3,8527,0)
 ;;=365.70^^58^610^31
 ;;^UTILITY(U,$J,358.3,8527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8527,1,3,0)
 ;;=3^Glaucoma,Stage NOS
 ;;^UTILITY(U,$J,358.3,8527,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,8527,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,8528,0)
 ;;=365.71^^58^610^17
 ;;^UTILITY(U,$J,358.3,8528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8528,1,3,0)
 ;;=3^Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,8528,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,8528,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,8529,0)
 ;;=365.72^^58^610^18
 ;;^UTILITY(U,$J,358.3,8529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8529,1,3,0)
 ;;=3^Glaucoma,Moderate Stage
 ;;^UTILITY(U,$J,358.3,8529,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,8529,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,8530,0)
 ;;=365.73^^58^610^30
 ;;^UTILITY(U,$J,358.3,8530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8530,1,3,0)
 ;;=3^Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,8530,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,8530,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,8531,0)
 ;;=365.74^^58^610^14
 ;;^UTILITY(U,$J,358.3,8531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8531,1,3,0)
 ;;=3^Glaucoma,Indeterm Stage
 ;;^UTILITY(U,$J,358.3,8531,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,8531,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,8532,0)
 ;;=V19.11^^58^610^5
 ;;^UTILITY(U,$J,358.3,8532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8532,1,3,0)
 ;;=3^Family Hx Glaucoma
 ;;^UTILITY(U,$J,358.3,8532,1,4,0)
 ;;=4^V19.11
 ;;^UTILITY(U,$J,358.3,8532,2)
 ;;=^340617
 ;;^UTILITY(U,$J,358.3,8533,0)
 ;;=V19.19^^58^610^6
 ;;^UTILITY(U,$J,358.3,8533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8533,1,3,0)
 ;;=3^Family Hx Oth Spec Eye Disord
 ;;^UTILITY(U,$J,358.3,8533,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,8533,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,8534,0)
 ;;=365.62^^58^610^8
